Monday, June 22, 2020

COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir

COVID-19 treatment | Gilead to begin clinical trials of inhaled version of remdesivir Gilead Sciences says it also expects to supply remdesivir to treat more than two million COVID-19 patients by year-end.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-treatment-|-gilead-to-begin-clinical-trialsinhaled-versionremdesivir_13940301.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...